NIMH Chemical Synthesis and Drug Supply Program

Compound Information Page

Compound Name: 5-(S)-Cysteinyl-L-DOPA
NIMH Code: C-702
Alternative Name:
Abbreviation:
Indications: melanoma biomarker
Package Sizes:
References: I. Wimmer, J. C. Meyer, B. Seifert, R. Dummer, A. Flace and G. Burg, Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy, Cancer Res., 57, 5073-5076 (1997); S. Ito, S. Inoue, Y. Yamamoto and K. Fujita, Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds, J. Med. Chem., 24, 673-677 (1981); S. Ito, K. Fujita, M. Yoshioka, D. Sienko and T. Nagatsu, Identification of 5-S- and 2-S-cysteinyldopamine and 5-S-glutathionyldopamine formed from dopamine by high-performance liquid chromatography with electrochemical detection, J. Chromatogr., 375, 134-140 (1986).
CAS:
Molecular Formula: C12H16N2O6S
HBA: 9
HBD: 6
RotB: 7
PubChemID:
AlogP: -4.660253
TPSA: 192.4
Activity:
Comments: Available as free base, dihydrochloride or bis(trifluoroacetate)
Last Updated 2008-11-11 02:32 PM
Structure of C-702
About The Program

Since 1959, the NIMH Chemical Synthesis and Drug Supply Program has synthesized and distributed novel research chemicals, psychoactive drugs, and compounds that are unavailable from commercial sources to the scientific community working on research relevant to mental health.

Content © 2014. «RTI International».